Is Your Sleep Problem Actually a Vitamin D Problem?
Quick answers
- Does low vitamin D cause sleep problems?
- A modest, real effect shows up in meta-analyses of vitamin D supplementation trials [5, 6], but the size and consistency vary a lot between studies, and a systematic review focused specifically on restless legs syndrome found no significant benefit from vitamin D [7]. It is one contributor among several, not an established primary cause.
- Does taking vitamin D deplete your B vitamins?
- That specific causal chain comes from one neurologist's clinical observations across her own patients, published as a hypothesis paper rather than tested in a controlled trial [2]. It has not been independently replicated, so it is worth treating as a plausible idea rather than an established mechanism.
- Is a vitamin D level of 60 to 80 ng/mL something to aim for?
- That target is one clinician's personal treatment threshold, not a figure from a trial or a guideline [2]. Laboratory reference ranges commonly flag levels below 30 ng/mL, a cutoff drawn from the Endocrine Society's 2011 guideline [9], well below her range, and that guideline explicitly says there is not enough evidence to justify screening people who are not at risk for deficiency [9]. Sustaining a level as high as 60 to 80 requires monitoring, and doing it without supervision carries real risk.
Probably not, at least not in the way the popular version of this theory says. Vitamin D supplementation does modestly improve sleep quality in meta-analyses, with a lot of variation between studies [5, 6], and a systematic review focused on restless legs syndrome found no significant benefit from it at all [7]. The larger claim circulating alongside that, that correcting vitamin D deficiency depletes B vitamins by changing gut bacteria and that you should aim for a blood level of 60 to 80 ng/mL, comes from one neurologist's own case series published as a hypothesis paper [1, 2]. No independent group has tested it.
You do everything the sleep advice tells you to do. Blackout curtains, a cool room, the same bedtime, the phone left in another room. You are still awake at three, or you slept eight hours and cannot explain why you feel like you didn't.
A neurologist then practicing in Tyler, Texas, named Stasha Gominak thinks she found the missing variable in patients who looked exactly like that, and by her account it was not sleep hygiene at all. It was vitamin D, followed by a cascade involving the gut microbiome and B vitamins.
Her explanation has been circulating widely on health podcasts, most recently a long conversation with Steven Bartlett on The Diary of a CEO, and it is compelling: an accidental clinical finding, a large personal case series, a mechanism that reaches from headaches to mood to gut symptoms to stroke risk with one connecting thread. A PubMed search on her name turns up nothing from an independent research group testing it, and it is published in a journal built specifically to host untested ideas. Both things can be true at once. Sorting out which parts are established and which parts are one clinician's working theory matters here, because the practical upshot involves people dosing themselves with a hormone, sometimes at doses more than ten times the recommended daily intake.
What she actually published, and what that journal is
Gominak's core claims appear in two papers, both in a journal called Medical Hypotheses. The first, written with the vitamin D anatomist Walter Stumpf, proposed that widespread vitamin D deficiency explains the modern rise in sleep disorders, based on an uncontrolled trial in 1,500 of her own neurology patients and on anatomical work showing vitamin D receptors in brain regions involved in sleep-wake regulation [1]. The second extended the theory: that correcting vitamin D deficiency over several years quietly drains the gut of the bacteria that manufacture B vitamins, particularly pantothenic acid, and that restoring both together produced better sleep, less pain, and resolved bowel symptoms in her practice [2].
Medical Hypotheses is exactly what its name says. After a 2010 controversy over the papers it had published, its publisher put external peer review in place, so both of Gominak's papers were reviewed. But that review checks whether an argument is coherent and worth investigating, not whether it is backed by original data or trial evidence. The journal's own purpose is to publish plausible ideas so someone else can test them, and that has not changed. That is not a criticism of the journal or of Gominak's clinical instincts, which by her account came from noticing patterns across many patients that standard sleep medicine did not explain. It is a statement about where these two papers sit on the evidence ladder. A hypothesis published there has the same standing as a well-argued case series presented at a conference: worth taking seriously, not yet worth treating as established.
The parts that independent research does support
Some of the underlying biology checks out.
Vitamin D receptors genuinely exist in brainstem and midbrain regions tied to sleep, arousal, and autonomic control. Stumpf's anatomical work mapped them there directly: a representative study in hamsters found receptor binding scattered through cranial nerve nuclei, the reticular formation, and other brainstem sites involved in motor, sensory, and autonomic regulation, the same general territory her theory depends on [3]. That is a real anatomical basis, not an invented one.
The acetylcholine link is thinner. In rats, giving 1,25-dihydroxyvitamin D3 increased activity of choline acetyltransferase, the enzyme that makes acetylcholine, but the effect was measured in the arcuate nucleus of the hypothalamus and the bed nucleus of the stria terminalis, not in the brainstem nuclei that actually control REM sleep and muscle paralysis, which is where her theory needs it [4]. It shows the mechanism is biologically plausible somewhere in the brain. It does not show it happening where she says it happens.
Vitamin D supplementation does move the needle on sleep in people, modestly. A 2022 meta-analysis of five trials found a statistically significant improvement in sleep quality scores with vitamin D supplementation, though the studies varied enough from each other that the finding should be read cautiously [5]. A separate review, published online in 2021, pooled dietary supplement trials and found vitamin D, along with amino acids and melatonin, produced a significant improvement in subjective sleep quality, again with high variability between studies [6]. Real effect, inconsistent size.
And vitamin D supplementation does shift gut bacteria. A 2026 systematic review of fourteen randomized controlled trials found that vitamin D supplementation increased populations of Bifidobacterium and Lactobacillus and shifted the ratio of two major bacterial phyla, with effects that varied by dose, duration, and starting vitamin D level [8]. That is a genuinely interesting, actively studied area, and it is the piece of Gominak's theory with the most independent support behind it.
The parts that are still just her theory
The specific causal chain, that correcting vitamin D deficiency depletes pantothenic acid and B vitamins by changing gut bacteria, and that this in turn drives insomnia, headache, and pain, comes entirely from Gominak's own case series [2]. No independent group has tested it. It has not been reproduced in a controlled trial. That does not make it wrong. It makes it unproven, which is a different thing.
The target blood level she describes, 60 to 80 ng/mL, also comes from her clinical experience rather than from trial data. Laboratory reference ranges commonly flag levels below 30 ng/mL as insufficient, a cutoff drawn from the Endocrine Society's 2011 guideline [9], and her range sits well above that. That guideline, drafted by a task force of endocrinologists reviewing the available evidence, explicitly states there is not enough evidence to recommend screening people who are not at risk for deficiency, or to prescribe vitamin D for non-bone benefits such as cardiovascular protection [9]. When this theory gets discussed, that guideline is often paraphrased as doctors being told not to be curious about vitamin D. That is not what it says. It says the evidence available in 2011 did not support screening low-risk people or prescribing vitamin D beyond bone-related uses, a narrower and more defensible position than telling doctors to stop asking questions. And in 2024 the Endocrine Society replaced that guideline with one that goes further still, suggesting against routine vitamin D testing in all the populations it considered and against supplementation above the standard recommended intake in healthy adults under 75 [10]. If anything, the newer guideline strengthens the caution this piece is urging.
And the theory does not hold up equally well across every sleep-related condition it claims to explain. A 2024 systematic review of dietary supplements for restless legs syndrome, a condition Gominak's framework would predict should respond to vitamin D, found that vitamin D supplementation did not show significant benefit, while magnesium and vitamin B6 did [7]. If vitamin D correction were the master key this theory suggests, that is an odd result. It is a useful reminder that a compelling unifying story can still be wrong about some of what it claims to unify.
The safety question high-dose vitamin D raises
Some of what circulates alongside the vitamin D sleep theory involves people taking 10,000, 20,000, even 30,000 IU of vitamin D daily, for years, without lab monitoring. Vitamin D is fat-soluble and accumulates in the body rather than being cleared like a water-soluble vitamin. Sustained high-dose supplementation without checking blood levels carries a real risk of hypercalcemia, and correcting a genuine deficiency is a different clinical situation than maintaining a level well above what most labs call sufficient indefinitely. If you are going to test and treat vitamin D deficiency, and there is decent reason to think many people should, that belongs with a clinician who is checking your levels along the way, not with a dose copied from a podcast.
Where I land on the vitamin D sleep theory
I don't think Gominak is wrong to notice what she noticed. Running vitamin D and B vitamin levels on hundreds of patients that standard sleep medicine had already failed, and paying attention when the textbook explanation didn't fit what she was seeing, is exactly the instinct root-cause work depends on.
What I don't trust is the leap from noticing to knowing. A single clinician's pattern across her own patients, published in a journal that doesn't require anyone else to check the data, is the beginning of a real investigation, not the end of one. The parts of her theory that other researchers have actually gone and tested hold up, modestly. The parts nobody else has tested yet are still just a well-told story. I would rather sit with that discomfort than round it up to certainty in either direction, and I would want the same patience from anyone telling you what your own labs mean.
What would actually settle this question?
The fix for an unreplicated hypothesis is not louder retelling. It is somebody else running the trial.
A real test would randomize a large group of adults with unexplained insomnia to vitamin D alone, vitamin D plus B-complex, and placebo, and measure sleep with polysomnography rather than self-report. It would need to run long enough to catch what Gominak describes: patients who improved on vitamin D alone for roughly two years before pain and insomnia crept back in, alongside a claimed B-vitamin deficiency. The trials pooled into the meta-analyses above ran weeks to a few months [5, 6], which would miss that window entirely. It would need stool sequencing to check whether the microbiome shift she describes is real and not just plausible, and blood markers of pantothenic acid status rather than inferring deficiency from symptoms improving on B100.
Nobody has run that trial. Until somebody does, treating this as settled, in either direction, is premature. That is also a fair ask of any clinician recommending it to patients right now: know which parts you are prescribing on the strength of a published hypothesis rather than a tested one, and say so. My hope in writing this is less that people adopt her protocol and more that a researcher with no stake in the outcome finally designs the study that would tell us whether she is right.
What should you do with this?
Treat the vitamin D sleep theory as a good question, not a settled answer. If your sleep has been resistant to the standard advice, a vitamin D level is a reasonable, cheap thing to ask your doctor to check, and the evidence that correcting a genuine deficiency modestly improves sleep quality is real, if not dramatic [5, 6]. The gut microbiome's role in supplying B vitamins is a legitimate and active research area worth watching [8], not a proven pathway to fixing insomnia.
What I would not do is self-dose at levels ten times the standard recommendation because one clinician's case series described it working for her patients. If you are already taking vitamin D anywhere near that range, ask whoever is treating you to check your blood level rather than assuming the dose is doing what you think it is doing. The honest position is that vitamin D probably matters more for sleep than mainstream sleep medicine has acknowledged, and that this particular explanation of how is still waiting on someone other than its author to check it.
Sources
- Gominak SC, Stumpf WE. The world epidemic of sleep disorders is linked to vitamin D deficiency. Med Hypotheses. 2012;79(2):132-135. doi.org/10.1016/j.mehy.2012.03.031
- Gominak SC. Vitamin D deficiency changes the intestinal microbiome reducing B vitamin production in the gut. The resulting lack of pantothenic acid adversely affects the immune system, producing a "pro-inflammatory" state associated with atherosclerosis and autoimmunity. Med Hypotheses. 2016;94:103-107. doi.org/10.1016/j.mehy.2016.07.007
- Stumpf WE, Bidmon HJ, Li L, Pilgrim C, Bartke A, Mayerhofer A, Heiss C. Nuclear receptor sites for vitamin D-soltriol in midbrain and hindbrain of Siberian hamster (Phodopus sungorus) assessed by autoradiography. Histochemistry. 1992;98(3):155-164. doi.org/10.1007/BF00315874
- Sonnenberg J, Luine VN, Krey LC, Christakos S. 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology. 1986;118(4):1433-1439. doi.org/10.1210/endo-118-4-1433
- Mirzaei-Azandaryani Z, Abdolalipour S, Mirghafourvand M. The effect of vitamin D on sleep quality- a systematic review and meta-analysis. Nutr Health. 2022;28(4):515-526. doi.org/10.1177/02601060221082367
- Chan V, Lo K. Efficacy of dietary supplements on improving sleep quality- a systematic review and meta-analysis. Postgrad Med J. 2022;98(1158):285-293. doi.org/10.1136/postgradmedj-2020-139319
- González-Parejo P, Martín-Núñez J, Cabrera-Martos I, Valenza MC. Effects of Dietary Supplementation in Patients with Restless Legs Syndrome- A Systematic Review. Nutrients. 2024;16(14):2315. doi.org/10.3390/nu16142315
- Zeb F, Osaili T, Hashim M, et al. Effect of Vitamin D Supplementation on Human Gut Microbiota- A Systematic Review of Randomized Controlled Trials. Nutr Rev. 2026;84(6):1157-1166. doi.org/10.1093/nutrit/nuaf120
- Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency- an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. doi.org/10.1210/jc.2011-0385
- Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease- an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. doi.org/10.1210/clinem/dgae290